日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SHP2 promotes osteosarcoma via regulating STAT3/TET3/HOXB2 signaling.

SHP2 通过调节 STAT3/TET3/HOXB2 信号通路促进骨肉瘤的发生发展。

Yang Hua, Ji Jiangfeng

TET3 regulates hematopoietic stem cell homeostasis during embryonic and adult hematopoiesis

TET3在胚胎和成体造血过程中调节造血干细胞稳态

Ketchum, Harmony C; Morganti, Claudia; Yanase, Chie; Ebert, Blake; Ito, Keisuke; Dawlaty, Meelad M

MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast Cancer.

MYC/TET3 调控的 TMEM65 激活 OXPHOS-SERPINB3 通路,促进三阴性乳腺癌的进展和顺铂耐药性。

Zhang Yin-Ling, Huang Min-Ying, Yang Shao-Ying, Cai Jia-Yang, Zhao Qian, Zhang Fang-Lin, Hu Xin, Shao Zhi-Min, Liao Li, Cao A-Yong, Li Da-Qiang

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma.

TET3/GATA6轴驱动胰腺导管腺癌的脂质代谢和治疗脆弱性。

Liu Shuai, Kang Shaobo, Lin Na, Zhang Wenqi, Wang Shiwen, Ren Yuqing, Ding Xiaofan, Yu Jianxiu, Xie Ruiyu

TET3 is a common epigenetic immunomodulator of pathogenic macrophages

TET3是致病性巨噬细胞中常见的表观遗传免疫调节因子。

Liu, Beibei; Dai, Yangyang; Wang, Zixin; Song, Jiahui; Du, Yushu; Lv, Haining; Bellone, Stefania; Yang, Yang-Hartwich; Kennedy, Andrew; Zhang, Songying; Venkatachalapathy, Muthukumaran; Surovtseva, Yulia; Wang, Penghua; Carmichael, Gordon G; Taylor, Hugh S; Zhang, Xuchen; Li, Da; Huang, Yingqun

TET3-overexpressing macrophages are a unifying pathogenic feature with therapeutic potential in chronic inflammatory diseases

TET3 过表达的巨噬细胞是慢性炎症疾病中具有治疗潜力的统一致病特征。

Haji, Shojiro; Ogawa, Yoshihiro

Delivery of miR-29a/29c-3p by serum exosomes promotes osteogenesis through TET3-dependent Sox9 demethylation and PI3K/Akt activation

血清外泌体递送的 miR-29a/29c-3p 通过 TET3 依赖的 Sox9 去甲基化和 PI3K/Akt 激活促进成骨作用。

Lin, Qing; Sun, Weipeng; Zhao, Biyi; Huang, Jiajia; Huang, Honghao; Jin, Xueshan; Zou, Yun; Yang, Li; Zhu, Xiaofeng; Zhang, Ronghua; Li, Xiaoyun

Peptide-functionalized periodic mesoporous silica nanoparticles for monocyte-specific TET3 Silencing enhance cardiac repair after acute myocardial infarction

肽功能化的周期性介孔二氧化硅纳米粒子可特异性沉默单核细胞中的TET3,从而增强急性心肌梗死后的心脏修复。

Jin, Hao; Ding, Jiandong; Zhang, Xiaoguo; Cheng, Shouquan; Zhang, Yahao; Wu, Yong; Liu, Cihui; Yang, Sirui; Zhang, Anjian; Ma, Genshan; Lu, Wenbin

Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer.

靶向 TET3 可抑制 3 组髓母细胞瘤干细胞特性和进展,其机制是通过损害 Otx2 超级增强子的低甲基化。

Chen Xuan, Wang Ziwei, Song Yan, Su Yu, Zhao Yahui, Li Jiankang, Wang Wei, Zhang Jiao, Daniels Craig, Wu Xiaochong, Saulnier Olivier, Wang Yanan, Liu Fei, Deng Kaiwen, Han Dongming, Liu Zijia, Li Meiyu, Hendrikse Liam D, Rasnitsyn Alexandra, Wang Evan Y, Wang Dongyang, Feng Zhaoyang, Li Yanong, Zhao Zitong, Yuan Hongyu, Sun Youliang, Jiang Yifei, Shi Yanfeng, Yang Tao, Qi Xueling, Hou Yong, Li Chunde, Liu Yong-Qiang, Tian Yu, Li Shuaicheng, Qiu Xiaoguang, Taylor Michael D, Li Guo Liang, Jiang Tao, Liu Hailong

TET3-Interacting LncRNA TILR Is Essential for DNA Hydroxymethylation-Mediated Neuroprotection After Ischemic Stroke

TET3相互作用的长链非编码RNA TILR在缺血性卒中后DNA羟甲基化介导的神经保护中起着至关重要的作用

Arruri, Vijay; Morris-Blanco, Kahlilia C; Mehta, Suresh L; Kaur, Mehakpreet; Vemuganti, Raghu